Transthyretin (TTR) Amyloid Cardiomyopathy Clinical Trial
Official title:
Vyndaqel Capsules Special Investigation - Investigation on Patients With Transthyretin Amyloid Cardiomyopathy
Secondary Data Collection : To confirm the safety and effectiveness profiles under the actual medical practice of Vyndaqel in Japan. This study is conducted in accordance with the protocol even when Vynmac is used, and information the use of Vynmac during the observation period is also collected.
To comprehend information on the long-term safety (e.g., onset status of adverse reactions), etc. of patients who are treated with Vyndaqel for the treatment of transthyretin amyloid cardiomyopathy. When Vynmac is used, conduct the study to grasp information on safety (e.g., onset status of adverse reactions),etc. during the observation period. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02791230 -
Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy
|
Phase 3 | |
| Completed |
NCT01994889 -
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
|
Phase 3 |